May 24, 2017 15:00 - 16:00 UTC
ISTH Core Curriculum 10.2 – Hypercoaguable States, 11.3, 11.5, 11.8 –Clinical Aspects of VTE, 13.1– Antithrombotic Agents
Marc Carrier "What is the role of cancer screening for patients with VTE?"
Aurélien Delluc"Management of incidentally-found VTE in cancer patients"
Additional bios coming soon!
Dr. Aurélien Delluc,M.D, Ph.D., is a Full Professor of internal medicine at the Western Brittany University, France, a physician in the Department of Internal Medicine and Chest Diseases at Brest University Hospital and a Senior Scientist in the “Groupe d’étude de la thrombose de Bretagne occidentale” Western Brittany Study Group on Thrombosis, EA3878, Ministère de l’Enseignement Supérieur et de la Recherche, France. He was born and trained in France.
His primary research interest is the evaluation of venous thromboembolism risk (VTE) including the overall epidemiology of VTE, links between atherothrombosis and VTE, cancer-associated thrombosis, and VTE risk associated with hospitalization. He is a member of the International Society on Thrombosis and Haemostasis, and a regular reviewer for thrombosis journals.
CLICK HERE TO SIGN IN AND REGISTER
Supported by an unrestricted educational grant from: